Financials

  • Market Capitalization 384.05 M
  • Employee 149
  • Founded 2018
  • CEO N/A
  • Website www.kyvernatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00RCYMHR1
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-2.58
주가매출액비율
-6 934.07

Related tickers

#이름가격24h %7d %1M %1Y %마켓 캡이전 7일
3024
GALT
Galectin Therapeutics Inc. - Common Stock
3.87 USD-1.78%+3.20%-2.03%-24.56%390.29 M USD
3028
IRD
Opus Genetics, Inc. - Common Stock
4.64 USD-0.22%+4.27%-22.92%+24.73%386.03 M USD
3034
ZURA
Zura Bio Limited - Class A Ordinary shares
4.00 USD0.00%+0.76%-23.22%+6.10%383.32 M USD
3052
CCCC
C4 Therapeutics, Inc. - Common Stock
3.06 USD-3.16%+1.32%-11.56%+45.71%376.46 M USD